Anti-PD1 antibody(CureImmune Therapeutics)

N/A

Report date: 2025/02/18 10:49:58

Base Information

Drug NameAnti-PD1 antibody(CureImmune Therapeutics)
Drug Alias NameCIT-100
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCureImmune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCureImmune Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A